News

Glow Lifetech Reports Positive Preliminary Results from Clinical Study of Artemic Support® on Patients with Long COVID Syndrome

Glow Announces Extension of Warrant Expiry

Glow Provides Update on Cannabis Development Activities and Ongoing Clinical Studies

Glow Completes Reactor Commissioning and Initiates Development of Proprietary MyCell® Water-Soluble Cannabis Ingredients

Glow Appoints Scientific & Regulatory Expert Advisors to Advance Commercial Activities

Glow Lifetech Announces Commencement of Clinical Study of Artemic Support® Featuring MyCell® Technology on Patients with Long COVID

Glow Completes Buildout of Canadian Facility and Begins Commissioning Proprietary Reactor

Glow Engages Regulatory Consultant Firms to Advance Commercialization of Artemic™ and Other Nutraceutical Ingredients in U.S. and Mexico